Who decides when to cleave an ectodomain?

Trends in Biochemical Sciences

Volumn 38, Issue 3, 2013, Pages 111-120

  Hartmann, Monika ^a   Herrlich, Andreas ^b   Herrlich, Peter ^a  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; CALNEXIN; CALRETICULIN; EPIDERMAL GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN; METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

BINDING AFFINITY; CATALYSIS; CRYSTALLIZATION; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; NONHUMAN; OSMOTIC STRESS; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

ADAM PROTEINS; ANIMALS; HUMANS; MODELS, BIOLOGICAL;

EID: 84874253212     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2012.12.002     Document Type: Review

References (89)

1. Essick E., et al. Pervanadate-induced shedding of the intercellular adhesion molecule (ICAM)-1 ectodomain is mediated by membrane type-1 matrix metalloproteinase (MT1-MMP). Mol. Cell. Biochem. 2008, 314:151-159.
2. Selvais C., et al. Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function. FASEB J. 2011, 25:2770-2781.
3. Klein T., Bischoff R. Active metalloproteases of the A Disintegrin and Metalloprotease (ADAM) family: biological function and structure. J. Proteome Res. 2011, 10:17-33.
4. Sahin U., Blobel C.P. Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17. FEBS Lett. 2007, 581:41-44.
5. Hartmann D., et al. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for α-secretase activity in fibroblasts. Hum. Mol. Genet. 2002, 11:2615-2624.
6. Jorissen E., et al. The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J. Neurosci. 2010, 30:4833-4844.
7. Jackson L.F., et al. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 2003, 22:2704-2716.
8. Nanba D., et al. Loss of HB-EGF in smooth muscle or endothelial cell lineages causes heart malformation. Biochem. Biophys. Res. Commun. 2006, 350:315-321.
9. Peschon J.J., et al. An essential role for ectodomain shedding in mammalian development. Science 1998, 282:1281-1284.
10. Sibilia M., Wagner E.F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 1995, 269:234-238.
11. Mann G.B., et al. Mice with a null mutation of the TGF α gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 1993, 73:249-261.
12. Laouari D., et al. TGF-α mediates genetic susceptibility to chronic kidney disease. J. Am. Soc. Nephrol. 2011, 22:327-335.
13. Lautrette A., et al. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Nat. Med. 2005, 11:867-874.
14. Asakura M., et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 2002, 8:35-40.
15. Yan X., Morgan J.P. Neuregulin1 as novel therapy for heart failure. Curr. Pharm. Des. 2011, 17:1808-1817.
16. Hynes N.E., MacDonald G. ErbB receptors and signaling pathways in cancer. Curr. Opin. Cell Biol. 2009, 21:177-184.
17. McDermott M.F., et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999, 97:133-144.
18. Dang M., et al. Epidermal growth factor (EGF) ligand release by substrate-specific a disintegrin and metalloproteases (ADAMs) involves different protein kinase C (PKC) isoenzymes depending on the stimulus. J. Biol. Chem. 2011, 286:17704-17713.
19. Herrlich A., et al. Ectodomain cleavage of the EGF ligands HB-EGF, neuregulin1-β, and TGF-α is specifically triggered by different stimuli and involves different PKC isoenzymes. FASEB J. 2008, 22:4281-4295.
20. Prenzel N., et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999, 402:884-888.
21. Horiuchi K., et al. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol. Biol. Cell 2007, 18:176-188.
22. Schlöndorff J., et al. Intracellular maturation and localization of the tumour necrosis factor α convertase (TACE). Biochem. J. 2000, 1:131-138.
23. Mochizuki S., Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci. 2007, 98:621-628.
24. Edwards D.R., et al. The ADAM metalloproteinases. Mol. Aspects Med. 2008, 29:258-289.
25. Hayashida K., et al. Molecular and cellular mechanisms of ectodomain shedding. Anat. Rec. (Hoboken) 2010, 293:925-937.
26. Bell J.H., et al. Role of ADAM17 in the ectodomain shedding of TNF-α and its receptors by neutrophils and macrophages. J. Leukoc. Biol. 2007, 82:173-176.
27. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23-35.
28. Díaz-Rodríguez E., et al. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor α-converting enzyme at threonine 735: a potential role in regulated shedding. Mol. Biol. Cell 2002, 13:2031-2044.
29. Göoz M., et al. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-α-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells. J. Biol. Chem. 2006, 281:21004-21012.
30. Xu P., Derynck R. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol. Cell 2010, 37:551-566.
31. Fan H., Derynck R. Ectodomain shedding of TGF-α and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J. 1999, 18:6962-6972.
32. Swendeman S., et al. VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circ. Res. 2008, 103:916-918.
33. Le Gall S.M., et al. ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site. J. Cell Sci. 2010, 123:3913-3922.
34. Willems S.H., et al. Thiol isomerases negatively regulate the cellular shedding activity of ADAM17. Biochem. J. 2010, 428:439-450.
35. Wang Y., et al. Regulation of mature ADAM17 by redox agents for L-selectin shedding. J. Immunol. 2009, 182:2449-2457.
36. Fortini M.E. Notch signaling: the core pathway and its posttranslational regulation. Dev. Cell 2009, 16:633-647.
37. Bozkulak E.C., Weinmaster G. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Mol. Cell. Biol. 2009, 29:5679-5695.
38. Gordon W.R., et al. Structural basis for autoinhibition of Notch. Nat. Struct. Mol. Biol. 2007, 14:295-300.
39. Meloty-Kapella L. Notch ligand endocytosis generates mechanical pulling force dependent on dynamin, epsins, and actin. Dev. Cell 2012, 22:1299-1312.
40. Janes P.W., et al. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 2005, 123:291-304.
41. Janes P.W., et al. Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10. PLoS Biol. 2009, 7:e1000215.
42. Wybenga-Groot L.E., et al. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell 2001, 106:745-757.
43. Gardiner E.E., et al. Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. Blood 2004, 104:3611-3617.
44. Jung S.M., et al. Constitutive dimerization of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood. J. Biol. Chem. 2012, 287:30000-30013.
45. Bohlson S.S., et al. CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma. J. Immunol. 2005, 175:1239-1247.
46. Contin C., et al. Membrane-anchored CD40 is processed by the tumor necrosis factor-α-converting enzyme. Implications for CD40 signaling. J. Biol. Chem. 2003, 278:32801-32809.
47. Palecanda A., et al. Rapid activation-independent shedding of leukocyte L-selectin induced by cross-linking of the surface antigen. Eur. J. Immunol. 1992, 22:1279-1286.
48. Nakayama H., et al. Cell surface annexins regulate ADAM-mediated ectodomain shedding of proamphiregulin. Mol. Biol. Cell 2012, 23:1964-1975.
49. Yáñez-Mó M., et al. Membrane proteases and tetraspanins. Biochem. Soc. Trans. 2011, 39:541-546.
50. Higashiyama S., et al. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J. Cell Biol. 1995, 128:929-938.
51. Deng W., et al. Interaction of calmodulin with L-selectin at the membrane interface: implication on the regulation of L-selectin shedding. J. Mol. Biol. 2011, 411:220-233.
52. Kahn J., et al. Calmodulin regulates L-selectin adhesion molecule expression and function through a protease-dependent mechanism. Cell 1998, 92:809-818.
53. 2+ influx and PKC activation. J. Cell Biol. 2004, 165:893-902.
54. Killock D.J., Ivetić A. The cytoplasmic domains of TNFα-converting enzyme (TACE/ADAM17) and L-selectin are regulated differently by p38 MAPK and PKC to promote ectodomain shedding. Biochem. J. 2010, 428:293-304.
55. Darmellah A., et al. Ezrin/radixin/moesin are required for the purinergic P2X7 receptor (P2X7R)-dependent processing of the amyloid precursor protein. J. Biol. Chem. 2012, 287:34583-34595.
56. Murai T., et al. Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J. Biol. Chem. 2004, 279:4541-4550.
57. Shi M., et al. Antibody-induced shedding of CD44 from adherent cells is linked to the assembly of the cytoskeleton. J. Immunol. 2001, 167:123-131.
58. Middelhoven P.J., et al. Actin polymerization induces shedding of FcγRIIIb (CD16) from human neutrophils. Biochem. Biophys. Res. Commun. 1999, 255:568-574.
59. Shaw A.S. Lipid rafts: now you see them, now you don't. Nat. Immunol. 2006, 7:1139-1142.
60. Rubinstein E. The complexity of tetraspanins. Biochem. Soc. Trans. 2011, 39:501-505.
61. Fitzgerald M.L., et al. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J. Cell Biol. 2000, 148:811-824.
62. Izumi Y., et al. A metalloprotease-disintegrin, MDC9/meltrin-γ/ADAM9 and PKCδ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 1998, 17:7260-7272.
63. Kveiborg M., et al. PKCα and PKCδ regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways. PLoS ONE 2011, 6:e17168.
64. Thabard W., et al. Protein kinase C delta and eta isoenzymes control the shedding of the interleukin 6 receptor alpha in myeloma cells. Biochem. J. 2001, 358:193-200.
65. Wheeler D.L., et al. Protein kinase Ce{open} is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-α ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Ce{open} transgenic mice. Cancer Res. 2003, 63:6547-6555.
66. Esper R.M., Loeb J.A. Neurotrophins induce neuregulin release through protein kinase Cδ activation. J. Biol. Chem. 2009, 284:26251-26260.
67. Liu X., et al. Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tail. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:13024-13029.
68. Liu X., et al. Release of the neuregulin functional polypeptide requires its cytoplasmic tail. J. Biol. Chem. 1998, 273:34335-34340.
69. Kohlstedt K., et al. CK2 phosphorylates the angiotensin-converting enzyme and regulates its retention in the endothelial cell plasma membrane. Circ. Res. 2002, 91:749-756.
70. Cheng H.J., Flanagan J.G. Transmembrane kit ligand cleavage does not require a signal in the cytoplasmic domain and occurs at a site dependent on spacing from the membrane. Mol. Biol. Cell 1994, 5:943-953.
71. Crowe P.D., et al. Specific induction of 80-kDa tumor necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation. J. Immunol. 1993, 151:6882-6890.
72. Neumann S., et al. Amyloid precursor-like protein 1 influences endocytosis and proteolytic processing of the amyloid precursor protein. J. Biol. Chem. 2006, 281:7583-7594.
73. Fukuda S., et al. Monoubiquitination of pro-amphiregulin regulates its endocytosis and ectodomain shedding. Biochem. Biophys. Res. Commun. 2012, 420:315-320.
74. 2+ for cancer cell proliferation and survival. Nat. Rev. Cancer 2008, 8:361-375.
75. Gschwind A., et al. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J. 2003, 22:2411-2421.
76. Reddy P., et al. Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme. J. Biol. Chem. 2000, 275:14608-14614.
77. Lemmon M.A., Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010, 141:1117-1134.
78. Xu P., et al. TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association. Sci. Signal. 2012, 5:ra34.
79. Ikawa M., et al. Calsperin is a testis-specific chaperone required for sperm fertility. J. Biol. Chem. 2011, 286:5639-5646.
80. Tokuhiro K., et al. Protein disulfide isomerase homolog PDILT is required for quality control of sperm membrane protein ADAM3 and male fertility. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:3850-3855.
81. Hatahet F., Ruddock L.W. Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. Antioxid. Redox Signal. 2009, 11:2807-2850.
82. Lichtenthaler S.F. Cell biology. Sheddase gets guidance. Science 2012, 335:179-180.
83. Carey R.M., et al. Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin. BMC Cell Biol. 2011, 12:20.
84. Bridges L.C., Bowditch R.D. ADAM-integrin interactions: potential integrin regulated ectodomain shedding activity. Curr. Pharm. Des. 2005, 11:837-847.
85. Göoz P., et al. A disintegrin and metalloenzyme (ADAM) 17 activation is regulated by α5β1 integrin in kidney mesangial cells. PLoS ONE 2012, 7:e33350.
86. Takeda S., et al. Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold. EMBO J. 2006, 25:2388-2396.
87. Hiraoka Y., et al. Enhancement of α-secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin. J. Neurochem. 2007, 102:1595-1605.
88. Hiraoka Y., et al. Ectodomain shedding of TNF-α is enhanced by nardilysin via activation of ADAM proteases. Biochem. Biophys. Res. Commun. 2008, 370:154-158.
89. Hospital V., Prat A. Nardilysin, a basic residues specific metallopeptidase that mediates cell migration and proliferation. Protein Pept. Lett. 2004, 11:501-508.